Nevertheless, it has been reported at least in one patient with ASD with clinically relevant high anti-GAD65 antibodies and comorbid type I diabetes, that there was a relevant benefit from therapy with IVIGs [64]. Here, GAD2 is linked to type 1 diabetes mellitus.